{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:22:18Z","timestamp":1740126138867,"version":"3.37.3"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1111\/bjd.16058","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T11:29:51Z","timestamp":1531999791000},"page":"14-15","source":"Crossref","is-referenced-by-count":0,"title":["The end of the beginning or the beginning of the end?"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-4929","authenticated-orcid":false,"given":"\u0141.","family":"Matusiak","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology; Wroclaw Medical University; 50-368 Wroc\u0142aw Cha\u0142ubi\u0144skiego 1 Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"10.1111\/bjd.16058-BIB0001|bjd16058-cit-0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/bjd.15255","article-title":"NICE approval of adalimumab for moderate-to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?","volume":"176","author":"Ingram","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16058-BIB0002|bjd16058-cit-0002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16058-BIB0003|bjd16058-cit-0003","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16058-BIB0004|bjd16058-cit-0004","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16058-BIB0005|bjd16058-cit-0005","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jaad.2015.07.053","article-title":"Treatment of hidradenitis suppurativa with biologic medications","volume":"73","author":"Lee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16058-BIB0006|bjd16058-cit-0006","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.15769","article-title":"Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16058-BIB0007|bjd16058-cit-0007","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.annder.2012.05.016","article-title":"Antibiotic treatment of hidradenitis suppurativa","volume":"139","author":"Revuz","year":"2012","journal-title":"Ann Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16058","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16058\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:30:17Z","timestamp":1676367017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/1\/14\/6732290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16058","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}